- Home
- HUBB vs PODD Comparison
HUBB vs PODD Comparison
Compare HUBB & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUBB
- PODD
- Stock Information
- Founded
- HUBB 1888
- PODD 2000
- Country
- HUBB United States
- PODD United States
- Employees
- HUBB N/A
- PODD N/A
- Industry
- HUBB Industrial Machinery/Components
- PODD Medical/Dental Instruments
- Sector
- HUBB Technology
- PODD Health Care
- Exchange
- HUBB Nasdaq
- PODD Nasdaq
- Market Cap
- HUBB 23.2B
- PODD 22.1B
- IPO Year
- HUBB N/A
- PODD 2007
- Fundamental
- Price
- HUBB $432.29
- PODD $333.21
- Analyst Decision
- HUBB Buy
- PODD Strong Buy
- Analyst Count
- HUBB 6
- PODD 18
- Target Price
- HUBB $477.83
- PODD $354.17
- AVG Volume (30 Days)
- HUBB 615.2K
- PODD 558.2K
- Earning Date
- HUBB 10-28-2025
- PODD 11-06-2025
- Dividend Yield
- HUBB 1.31%
- PODD N/A
- EPS Growth
- HUBB 15.10
- PODD N/A
- EPS
- HUBB 15.99
- PODD 3.45
- Revenue
- HUBB $5,686,200,000.00
- PODD $2,521,800,000.00
- Revenue This Year
- HUBB $6.12
- PODD $29.32
- Revenue Next Year
- HUBB $7.43
- PODD $18.37
- P/E Ratio
- HUBB $27.07
- PODD $96.41
- Revenue Growth
- HUBB 0.82
- PODD 27.11
- 52 Week Low
- HUBB $299.43
- PODD $230.05
- 52 Week High
- HUBB $484.26
- PODD $353.50
- Technical
- Relative Strength Index (RSI)
- HUBB 41.42
- PODD 59.08
- Support Level
- HUBB $453.08
- PODD $311.51
- Resistance Level
- HUBB $468.52
- PODD $341.03
- Average True Range (ATR)
- HUBB 15.05
- PODD 11.79
- MACD
- HUBB -3.50
- PODD 1.86
- Stochastic Oscillator
- HUBB 23.33
- PODD 84.08
About HUBB Hubbell Inc
Founded in 1888 by Harvey Hubbell, the eponymous company was the conduit through which the pull-chain lamp socket was originally sold. Hubbell has since grown into an electricity transmission and distribution behemoth, housing more than 75 brands that sell components found on power lines, electrical substations, and within commercial and industrial buildings. The company's primary operations are within the United States, where around 90% of revenue is derived.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.